- Home
- FLC vs SENS Comparison
FLC vs SENS Comparison
Compare FLC & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLC | SENS |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.5M | 225.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FLC | SENS |
|---|---|---|
| Price | $17.57 | $5.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.58 |
| AVG Volume (30 Days) | 37.8K | ★ 434.8K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $12.62 | $5.25 |
| 52 Week High | $15.45 | $28.00 |
Technical Indicators
Market Signals| Indicator | FLC | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 41.68 |
| Support Level | $17.33 | $5.41 |
| Resistance Level | $17.60 | $6.44 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 60.00 | 13.69 |
Price Performance
Historical ComparisonAbout FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.